Overview

Inhaled Steroid Treatment as Regular Therapy in Early Asthma

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
A study of the effect of the early treatment with Pulmicort of newly diagnosed asthma. Patients will receive either Pulmicort or a non-active treatment for three years. Neither patients or investigators will be aware of the treatment received. After three years of treatment all patients will receive Pulmicort for 2 further years.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide